"remarkable results" presented for adding Perjeta(pertuzumab)to Herceptin for StageIV

[Lani]

MOVING THIS UP AS IT IS THE MOST REMARKABLE HER2 NEWS EVER

THE MOST REMARKABLE BREAST CANCER NEWS EVER

AND ONE OF THE MOST REMARKABLE RESULTS EVER FOR ANY TREATMENT AGAINST ONE OF THE THREE MOST COMMON CANCERS.

FOR ALL THOSE NAY-SAYERS, WHO DEEMED IT DIDN'T MATTER WHAT AGENT OR COMBINATION OF AGENTS GIVEN OR WHAT ORDER GIVEN A STAGE FOR BREAST CANCER PATIENT WAS DOOMED DIE ON AVERAGE 2 YRS AFTER DIAGNOSIS, MUCH SOONER IF HER2 + (HEARD DR HAYES OF U OF MICHIGAN SAY THIS AT A BC MEETING IN May 2005--WHAT A DIFFERENCE 9 YEARS AND LOTS OF RESEARCH MAKES!!!